GFP+ tumor cells were isolated from enzymatically digested tumors and MRLs using fluorescence-activated cell sorting and subjected to expression profiling, along with GFP-negative stromal cells isolated from recurrent tumors in the HER2/neu model (Fig. 4a). The gene discussed is ERBB2; the disease is neoplasm.